Marker Therapeutics, Inc.

Monthly Archives: October 2014

TapImmune Provides Update on PolyStart™ Vaccine Platform Applicable to Cancer and Infectious Disease

Platform Technology is a novel platform for rapid development of Vaccines for Cancer and Multiple Emerging Viral Threats including Ebola, Enterovirus, and Smallpox. SEATTLE, WASHINGTON, October 22, 2014 — TapImmune, Inc.
Read More